Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EQ compared with PMN: revenue, margins and what each company keeps, and the suppliers and customers both name
EQ
Equillium, Inc.
Change
Mkt cap
Revenue
Revenue
PMN
ProMIS Neurosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EQ
Equillium, Inc.
vs
PMN
ProMIS Neurosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EQ
2
—
Biocon
unlisted
supplier
—
Ono Pharmaceutical
unlisted
customer
Shared
0
No disclosed counterparties: PMN.
Only PMN
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
EQ
Equillium, Inc.
Change
1.37
▲
+0.26%
· post 1.37
Mkt cap
$86.9M
Revenue
$4M
Q4 FY24
Revenue
$41M
FY24
PMN
ProMIS Neurosciences Inc.
Change
3.10
▼
−6.36%
· post 3.12
Closed
Nov 2 '26
Mkt cap
$29.7M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 2 '26
EQ
Equillium, Inc.
vs
PMN
ProMIS Neurosciences Inc.
1.37
▲
+0.26%
post 1.37
Price
3.10
▼
−6.36%
post 3.12
$86.9M
Mkt cap
$29.7M
Q4 FY24
$4M
Revenue
—
FY24
$41M
Revenue
—
Change
Change
EQ
1.37
▲
+0.26%
vs
PMN
3.10
▼
−6.36%
Closed
Nov 2 '26